40 reports

  • ALLERGY RHINITIS DRUGS MARKET IN APAC
  • ALLERGY RHINITIS DRUGS MARKET IN AMERICAS

Immunotherapies is one of the most lucrative segments of the Global allergy rhinitis drugs market owing to the increased drug development in this segment.

  • Allergy
  • Allergy Drug
  • Chronic Disease
  • OTC
  • Respiratory Disease
  • Birch Pollen Allergy - Drug Profiles
  • VACCINE FOR BIRCH POLLEN ALLERGY - DRUG PROFILE

The drug candidate acts by targeting pollen allergen Bet v ##.

  • Allergy
  • Immunotherapy
  • Germany
  • Product Initiative
  • Anergis SA
  • Birch Pollen Allergy - Drug Profiles
  • VACCINE FOR BIRCH POLLEN ALLERGY - DRUG PROFILE

The goal was to demonstrate safety and efficacy of recombinant Bet v ## for desensitization against birch pollen allergy.

  • Allergy
  • Allergy Immunotherapy
  • Immunotherapy
  • Therapy
  • Anergis SA
  • VACCINE FOR HOUSE DUST MITE ALLERGY - DRUG PROFILE
  • VACCINE FOR HOUSE DUST MITE ALLERGY - DRUG PROFILE

House Dust Mite Allergy - Pipeline by Zhejiang I-Biological Technology Co Ltd, H## 2019 ZHEJIANG I-BIOLOGICAL TECHNOLOGY CO LTD House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUS

  • Allergy
  • Medical Biotechnology
  • World
  • Product Initiative
  • Anergis SA
  • Cat Allergy - Drug Profiles
  • Sementis Ltd

Cat allergy is an allergic reaction to one or more allergens produced by cats.

  • Allergy
  • Chronic Disease
  • United States
  • World
  • Product Initiative
  • Grass Pollen Allergy - Drug Profiles
  • Vaccine for Grass Pollen Allergy - Drug Profile

Vaccine ## for Grass Pollen Allergy - Drug Profile Vaccine for Grass Pollen Allergy - Drug Profile Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Vaccine for Grass Pollen Allergy DC##U B

  • Allergy
  • Immunotherapy
  • Therapy
  • United States
  • Product Initiative
  • Cedar Pollen Allergy - Drug Profiles
  • BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE

About ## percent of people who have food allergies are allergic to more than one food.

  • Allergy
  • Medical Biotechnology
  • Japan
  • World
  • Product Initiative
  • Grass Pollen Allergy - Drug Profiles
  • Vaccine for Grass Pollen Allergy - Drug Profile

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Biotechnology
  • Immunotherapy
  • United States
  • Product Initiative
  • Ragweed Pollen Allergy - Drug Profiles
  • Allergan for Ragweed Pollen Allergy - Drug Profile

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Therapy
  • Biomay AG
  • Ragweed Pollen Allergy - Drug Profiles
  • Allergan for Rag Weed Pollen Allergy - Drug Profile

Food and Drug Administration (FDA) has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (## Amb a ##-U).

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • United States
  • Product Initiative
  • ALLERGEN FOR PEANUT ALLERGY - DRUG PROFILE
  • VACCINE FOR PEANUT ALLERGY - DRUG PROFILE

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Chronic Disease
  • Immunotherapy
  • Therapy
  • United States
  • Cedar Pollen Allergy - Drug Profiles
  • BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE

BIOLOGIC FOR CEDAR POLLEN ALLERGY - DRUG PROFILE OMALIZUMAB - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description omalizumab F.

  • Allergy
  • Therapy
  • Japan
  • World
  • Product Initiative
  • Peanut Allergy - Drug Profiles
  • ALLERGEN FOR PEANUT ALLERGY - DRUG PROFILE

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Chronic Disease
  • Pathology
  • Therapy
  • VACCINE FOR HOUSE DUST MITE ALLERGY - DRUG PROFILE
  • House Dust Mite Allergy - Drug Profiles

HOUSE DUST MITE ALLERGY - PIPELINE BY STALLERGENES GREER PLC, H## 2019 House Dust Mite Allergy - Drug Profiles ALLERGAN FOR DUST MITE ALLERGY - DRUG PROFILE ALLERGEN FOR ALLERGIC ASTHMA AND HOUSE DUST MITE ALLERGY - DRUG PROFILE AM-## -

  • Allergy
  • Medical Biotechnology
  • United States
  • World
  • Product Initiative
  • Cat Allergy - Drug Profiles
  • Allergen for Cat Allergy - Drug Profile

Cat allergy is an allergic reaction to one or more allergens produced by cats.

  • Allergy
  • Chronic Disease
  • United States
  • World
  • Product Initiative
  • 1.2 Types of Allergy
  • Types of Allergies

Drug Allergy- The allergy from medicines, drugs is the most common form of allergy.

  • Allergy
  • Respiratory Disease
  • World
  • Merck & Co., Inc.
  • Stallergenes Greer plc
  • 2.5 Types of Allergy by Allergens
  • Types of Allergy

The hypersensitivity of the body to sun rays causes sun allergy. ##. ## Types of Allergy by Allergens Drug Allergy-The allergy from medicines, drugs is the most common form of allergy.

  • Allergy
  • Allergy Immunotherapy
  • World
  • Market Size
  • Allergy Therapeutics plc
  • ALLERGEN FOR ALLERGIC RHINITIS, ALLERGIC RHINO-CONJUNCTIVITIS AND BIRCH POLLEN ALLERGY - DRUG PROFILE
  • Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen Allergy

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy
  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • Therapy
  • MARKET CHALLENGES
  • GEOGRAPHICAL SEGMENTATION

Environmental pollutants and few chemical substances present in food and drugs may cause different types of food, skin, and drug sensitive allergies and asthma.

  • Allergy
  • Diagnostics
  • Hospital
  • Laboratory
  • Danaher Corporation
  • LATEST CLINICAL TRIALS NEWS ON PEANUT ALLERGY

Hoffmann-La Roche Ltd ## ## ## ## ## AnaptysBio Inc ## ## ## ## ## Food Allergy Research & Education Inc ## ## ## ## ## Novartis AG ## ## ## ## ## Droege International Group AG ## ## ## ## ## Allertein Therapeutics LLC ## ## ## ## ## Allergy Therapeutics

  • Allergy
  • Medical Biotechnology
  • World
  • Product Initiative
  • Aimmune Therapeutics, Inc.
  • SUMMARIZES THE KEY PROJECTED PATENT EXPIRY DATES FOR PEANUT ALLERGY ACROSS THE 8MM.
  • KEY PROJECTED LAUNCH DATES FOR PEANUT ALLERGY, 2017-2027

WORLD ALLERGY ORGANIZATION JOURNAL, ##(##), PP. ##-##.

  • Allergy
  • Australia
  • World
  • Forecast
  • Aimmune Therapeutics, Inc.
  • 2.1 RELATED REPORTS
  • MM, Probable Diagnosed Prevalent Cases of Peanut Allergy, All Ages, Both Sexes, N, 2017 and 2027

Peanut Allergy: Global Drug Forecast and Market Analysis to 2027, GDHC##PIDR GlobalData (2016).

  • Agricultural Products
  • Allergy
  • United States
  • World
  • Forecast
  • Feb 12, 2018: ASIT Biotech 2017 Annual Results: Ongoing ASIT+ Products Development in Respiratory and Food Allergies

ASIT biotech also received a & euro## million non-diluting financing from the Walloon Region for a very promising food allergy drug development program with the objective to select, by the end of this year, at least one product candidate with an optimal immunogenicity.

  • Allergy
  • Healthcare
  • Belgium
  • Product Initiative
  • ASIT Biotech

Additionally, unpredictable allergies (with potentially severe reactions) to drugs and biological agents are becoming problematic.

  • Allergy
  • Chronic Disease
  • Pharmaceutical
  • World
  • Market Size
  • Major Companies

Stanford' s allergy clinics specialize in a range of allergic and immunological conditions, including asthma, eczema, food allergies, drug allergies and chronic urticaria (hives).

  • Allergy
  • Chronic Disease
  • United States
  • Forecast

Food and Drug Administration (FDA).

  • Allergy
  • Healthcare
  • Therapy
  • United States
  • Aimmune Therapeutics, Inc.
  • 5. All the trials included are unique trials.

ALLERGIES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS ALLERGIES THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* ALLERGIES THERAPEUTICS CLINICAL TR

  • Allergy
  • Clinical Trial
  • Pharmaceutical
  • Japan
  • World

Peanut Allergy Pipeline Compound Details Drug Details ##.

  • Allergy
  • Chronic Disease
  • World

Cat Allergy Pipeline Compound Details Drug Details ##.

  • Allergy
  • Chronic Disease
  • World

Ragweed Allergy Pipeline Compound Details Drug Details ##.

  • Allergy
  • Chronic Disease
  • World